These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30123183)

  • 41. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.
    Cassoni P; Fulcheri E; Carcangiu ML; Stella A; Deaglio S; Bussolati G
    J Pathol; 2000 Mar; 190(4):470-7. PubMed ID: 10699997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gonadal steroid regulation of oxytocin and oxytocin receptor gene expression.
    Zingg HH; Rozen F; Breton C; Larcher A; Neculcea J; Chu K; Russo C; Arslan A
    Adv Exp Med Biol; 1995; 395():395-404. PubMed ID: 8713994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
    Assinder SJ
    Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paracrine oxytocin and estradiol demonstrate a spatial increase in human intrauterine tissues with labor.
    Blanks AM; Vatish M; Allen MJ; Ladds G; de Wit NC; Slater DM; Thornton S
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3392-400. PubMed ID: 12843193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
    Ho CK; Nanda J; Chapman KE; Habib FK
    J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steroid hormones stimulate human prostate cancer progression and metastasis.
    Ricke WA; Ishii K; Ricke EA; Simko J; Wang Y; Hayward SW; Cunha GR
    Int J Cancer; 2006 May; 118(9):2123-31. PubMed ID: 16331600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
    Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
    Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.
    Dinh DT; Frauman AG; Somers GR; Ohishi M; Zhou J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2002 Feb; 196(2):213-9. PubMed ID: 11793373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of estrogen supplementation on cell proliferation and expression of c-kit positive cells in the rat prostate.
    Kusljic S; Exintaris B
    Prostate; 2010 Oct; 70(14):1555-62. PubMed ID: 20687229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and region-specific regulation of the oxytocin receptor gene in rat brain.
    Breton C; Zingg HH
    Endocrinology; 1997 May; 138(5):1857-62. PubMed ID: 9112379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and experimental studies of benign prostatic hyperplasia.
    Coffey DS; Walsh PC
    Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
    Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
    Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrauterine oxytocin system. Compartmental distribution of oxytocin and oxytocin receptors in rat endometrial epithelium.
    Morel G; Pechoux C; Raccurt M; Zingg HH
    Cell Tissue Res; 2001 Jun; 304(3):377-82. PubMed ID: 11456414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.
    Nascimento-Viana JB; Carvalho AR; Nasciutti LE; Alcántara-Hernández R; Chagas-Silva F; Souza PA; Romeiro LA; García-Sáinz JA; Noël F; Silva CL
    J Pharmacol Exp Ther; 2016 Jan; 356(1):212-22. PubMed ID: 26493747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J
    J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
    Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.